The tech bajillionaire may be up to a neat baker’s dozen of offspring, though only one has made a White House appearance.

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

Discover how Grail Inc. achieved 45% revenue growth, improved scalability with the updated Galleri test, and navigates legislative and market challenges.

Group One CFO Jesley Chua is helping to take Asia’s largest global sports property to its next stage of evolution.

Prior jobs include working for Guggenheim Partners, Brown Brothers Harriman and AXA Advisors. She has an economics degree from Bucknell University and a law degree from the Catholic University of ...

CEO Jason Wells highlighted the company’s non-GAAP EPS of $0.40 for the quarter and $1.62 for the full year 2024, translating to 8% growth over 2023. He reaffirmed the 2025 non-GAAP EPS guidance range ...

Signing nine players in the last two off-seasons and all promised nine figures! The post "Doing What the System Allows": Rob ...

ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines ...

Investment analysts at Wedbush cut their FY2025 EPS estimates for RH in a research report issued on Tuesday, February 18th.

ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today confirmed receipt of an ...

Allworth Financial LP raised its holdings in Ross Stores, Inc. (NASDAQ:ROST – Free Report) by 2.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,895 shares ...